Clinical Trial

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

Study acronym: CONCERTO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 3, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telescope (IMT) in patients with moderate-severe central vision loss due to late-stage age-related macular degeneration (AMD).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-06-24; most recent amendment 2024-11-27.
Trial Details
NCT Number NCT05438732
Lead Sponsor VisionCare, Inc.
Collaborators: ORA, Inc.
Conditions Age-Related Macular Degeneration, Geographic Atrophy
Enrollment 125 participants
Start Date 2022-06-16
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-03